Banka BioLoo Limited (NSE:BANKA)
India
· Delayed Price · Currency is INR 70.14
+0.73 (1.05%)
Jul 16, 2025, 9:30 AM IST
Banka BioLoo Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2016 - 2020 |
Operating Revenue | 541.74 | 499.96 | 423.5 | 387.51 | 304.58 | Upgrade
|
| 541.74 | 499.96 | 423.5 | 387.51 | 304.58 | Upgrade
| |
Revenue Growth (YoY) | 8.36% | 18.05% | 9.29% | 27.23% | -36.37% | Upgrade
|
Cost of Revenue | 451.05 | 402.79 | 293.34 | 246.27 | 169.32 | Upgrade
|
Gross Profit | 90.69 | 97.18 | 130.15 | 141.24 | 135.25 | Upgrade
|
Selling, General & Admin | - | 2.44 | 4.14 | 4.05 | 9.07 | Upgrade
|
Other Operating Expenses | 119.42 | 57.31 | 65.6 | 81.47 | 92.1 | Upgrade
|
Operating Expenses | 144.72 | 81.64 | 84.57 | 94.93 | 107.15 | Upgrade
|
Operating Income | -54.04 | 15.54 | 45.59 | 46.31 | 28.11 | Upgrade
|
Interest Expense | -37.61 | -22.76 | -15 | -16.41 | -14.65 | Upgrade
|
Interest & Investment Income | - | 3.78 | 5.56 | 3.91 | - | Upgrade
|
Earnings From Equity Investments | 0.28 | -0.21 | 0.06 | 0.27 | -0.02 | Upgrade
|
Currency Exchange Gain (Loss) | - | - | - | - | -0.02 | Upgrade
|
Other Non Operating Income (Expenses) | 3.28 | -1.99 | 0.03 | -0.97 | 5.27 | Upgrade
|
EBT Excluding Unusual Items | -88.09 | -5.63 | 36.24 | 33.11 | 18.68 | Upgrade
|
Impairment of Goodwill | -3.15 | - | - | - | - | Upgrade
|
Gain (Loss) on Sale of Assets | - | - | - | -0.03 | - | Upgrade
|
Pretax Income | -91.24 | -5.63 | 36.24 | 33.08 | 18.68 | Upgrade
|
Income Tax Expense | -2.15 | 1.08 | 10.85 | 2.01 | -3.36 | Upgrade
|
Earnings From Continuing Operations | -89.09 | -6.71 | 25.39 | 31.08 | 22.05 | Upgrade
|
Minority Interest in Earnings | - | 0.19 | - | - | -0 | Upgrade
|
Net Income | -89.09 | -6.53 | 25.39 | 31.08 | 22.05 | Upgrade
|
Net Income to Common | -89.09 | -6.53 | 25.39 | 31.08 | 22.05 | Upgrade
|
Net Income Growth | - | - | -18.30% | 40.95% | -64.59% | Upgrade
|
Shares Outstanding (Basic) | 11 | 11 | 11 | 10 | 10 | Upgrade
|
Shares Outstanding (Diluted) | 11 | 11 | 11 | 10 | 10 | Upgrade
|
Shares Change (YoY) | 0.47% | - | 4.85% | 0.18% | - | Upgrade
|
EPS (Basic) | -8.21 | -0.60 | 2.35 | 3.02 | 2.14 | Upgrade
|
EPS (Diluted) | -8.21 | -0.60 | 2.34 | 3.02 | 2.14 | Upgrade
|
EPS Growth | - | - | -22.44% | 40.98% | -64.67% | Upgrade
|
Free Cash Flow | -36.13 | -72.07 | 9.4 | -36 | 53.55 | Upgrade
|
Free Cash Flow Per Share | -3.33 | -6.67 | 0.87 | -3.50 | 5.21 | Upgrade
|
Gross Margin | 16.74% | 19.44% | 30.73% | 36.45% | 44.41% | Upgrade
|
Operating Margin | -9.98% | 3.11% | 10.76% | 11.95% | 9.23% | Upgrade
|
Profit Margin | -16.45% | -1.31% | 6.00% | 8.02% | 7.24% | Upgrade
|
Free Cash Flow Margin | -6.67% | -14.41% | 2.22% | -9.29% | 17.58% | Upgrade
|
EBITDA | -28.73 | 31.72 | 54.74 | 51.93 | 33.38 | Upgrade
|
EBITDA Margin | -5.30% | 6.35% | 12.93% | 13.40% | 10.96% | Upgrade
|
D&A For EBITDA | 25.31 | 16.19 | 9.15 | 5.62 | 5.27 | Upgrade
|
EBIT | -54.04 | 15.54 | 45.59 | 46.31 | 28.11 | Upgrade
|
EBIT Margin | -9.98% | 3.11% | 10.76% | 11.95% | 9.23% | Upgrade
|
Effective Tax Rate | - | - | 29.94% | 6.07% | - | Upgrade
|
Revenue as Reported | 545.01 | 504.91 | 430.51 | 392.05 | 310.34 | Upgrade
|
Advertising Expenses | - | 0.51 | 1.94 | 0.3 | 0.98 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.